IJH vs XLV
iShares Core S&P Mid-Cap ETF vs Health Care Select Sector SPDR Fund
- • IJH has the lower expense ratio at 0.05% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | IJH | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.22% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $115.69B | $37.88B |
YTD return | 13.32% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.08 | 0.58 |
P/E ratio | 21.71 | 26.68 |
Last price | $73.66 | $144.72 |
Inception | — | — |
Issuer | iShares | State Street |
IJH top holdings
| FLEX | Flex Ltd | 0.98% |
| FTI | TechnipFMC PLC | 0.89% |
| CW | Curtiss-Wright Corp | 0.78% |
| XPO | XPO Inc | 0.75% |
| UTHR | United Therapeutics Corp | 0.72% |
| FN | Fabrinet | 0.72% |
| MTZ | MasTec Inc | 0.71% |
| NVT | nVent Electric PLC | 0.67% |
| TWLO | Twilio Inc Class A | 0.66% |
| P | Everpure Inc Class A | 0.65% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About IJH
IJH (iShares Core S&P Mid-Cap ETF) is Tracks the S&P MidCap 400 index. Managed by iShares, the fund carries $115.7B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.22%. Its largest holding is Flex Ltd (FLEX), which represents 1.0% of the portfolio. Real Estate is the fund's largest sector exposure at 7.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.